Nanjing Pharmablock announces mandatory redemption of Yaoshi convertible bonds

Nanjing Pharmablock Sciences Co., Ltd. announced the upcoming mandatory redemption of its "Yaoshi convertible bond" (Stock Code: 123145), with the last trading day set for September 12, 2025. Following this, trading will cease. The final conversion date for these bonds is September 17, 2025. After this date, any remaining unconverted bonds will be compulsorily redeemed at a price of yuan 100.62 per bond, which includes the bond's face value and accrued interest.

The company's board of directors approved the early redemption on August 14, 2025, after the convertible bonds met the conditional redemption criteria outlined in their prospectus. This trigger occurred between July 25 and August 14, 2025, when the company's A-share stock price closed at or above 130% of the current conversion price (yuan 43.69 per share) for at least 15 trading days within a consecutive 30-day period.

Investors are reminded that to convert bonds into shares, a Shenzhen Stock Exchange ChiNext trading account is required. Those not meeting the ChiNext investor suitability requirements cannot convert their bonds into shares, potentially leading to investment losses if not converted before the deadline. The company will disclose redemption-related matters daily until the redemption date.